Entity Common Stock, Shares Outstanding of Kraig Biocraft Laboratories, Inc. from 12 Aug 2011 to 28 Mar 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Kraig Biocraft Laboratories, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Aug 2011 to 28 Mar 2025.
  • Kraig Biocraft Laboratories, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 28 Mar 2025 was 1,042,646,733, a 0.41% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Kraig Biocraft Laboratories, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 1,042,646,733 +4,272,514 +0.41% 28 Mar 2025 10-K 28 Mar 2025 2024 FY
Q1 2024 1,038,374,219 +5,000,000 +0.48% 01 Apr 2024 10-K 01 Apr 2024 2023 FY
Q1 2023 1,033,374,219 +82,469,175 +8.7% 29 Mar 2023 10-K 29 Mar 2023 2022 FY
Q3 2022 1,025,004,658 +117,246,210 +13% 14 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 978,777,724 +103,628,561 +12% 01 Aug 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 950,905,044 +96,495,043 +11% 16 Mar 2022 10-K 16 Mar 2022 2021 FY
Q3 2021 907,758,448 04 Nov 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 875,149,163 12 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 854,410,001 +9,941,623 +1.2% 12 Mar 2021 10-K 12 Mar 2021 2020 FY
Q1 2020 844,468,378 +8,734,538 +1% 27 Mar 2020 10-K 27 Mar 2020 2019 FY
Q3 2019 844,468,378 +27,584,468 +3.4% 08 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 0 -816,883,910 -100% 08 Aug 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 835,733,840 +18,885,930 +2.3% 29 Mar 2019 10-K 29 Mar 2019 2018 FY
Q3 2018 816,883,910 +14,687,162 +1.8% 12 Nov 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 816,883,910 +14,687,162 +1.8% 06 Aug 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 816,847,910 +35,885,053 +4.6% 15 Mar 2018 10-K 23 Mar 2018 2017 FY
Q3 2017 802,196,748 +30,065,487 +3.9% 14 Nov 2017 10-Q 15 Nov 2017 2017 Q3
Q2 2017 802,196,748 +38,686,556 +5.1% 10 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 780,962,857 +61,852,586 +8.6% 22 Mar 2017 10-K 22 Mar 2017 2016 FY
Q3 2016 772,131,261 +73,430,265 +11% 10 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 763,510,192 +72,869,944 +11% 10 Aug 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 719,110,271 +42,206,923 +6.2% 30 Mar 2016 10-K 30 Mar 2016 2015 FY
Q3 2015 698,700,996 +24,726,567 +3.7% 01 Nov 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 690,640,248 +23,439,478 +3.5% 11 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 676,903,348 +22,298,078 +3.4% 31 Mar 2015 10-K 31 Mar 2015 2014 FY
Q3 2014 673,974,429 +52,866,646 +8.5% 22 Oct 2014 10-Q 23 Oct 2014 2014 Q3
Q2 2014 667,200,770 12 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 654,605,270 +49,428,357 +8.2% 14 Apr 2014 10-K 15 Apr 2014 2013 FY
Q4 2013 632,178,269 +30,913,263 +5.1% 19 Nov 2013 10-Q 19 Nov 2013 2013 Q3
Q3 2013 621,107,783 +19,842,777 +3.3% 16 Aug 2013 10-Q/A 31 Dec 2013 2013 Q2
Q1 2013 605,176,913 +19,733,202 +3.4% 12 Apr 2013 10-K/A 24 Dec 2013 2012 FY
Q4 2012 601,265,006 16 Nov 2012 10-Q 19 Nov 2012 2012 Q3
Q3 2012 601,265,006 +28,241,411 +4.9% 17 Aug 2012 10-Q/A 10 Sep 2012 2012 Q2
Q1 2012 585,443,711 12 Apr 2012 10-K 12 Apr 2012 2011 FY
Q3 2011 573,023,595 11 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 580,290,676 12 Aug 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.